Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms

NCT02626572 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: S47445 5mg
DRUG: S47445 15mg
DRUG: S47445 50mg
DRUG: Placebo

Sponsor

Institut de Recherches Internationales Servier